Direct answer (40-60 words)
No. Mounjaro is only available as a subcutaneous injection. There is no FDA-approved oral, sublingual, or topical "drop" version of tirzepatide. Products marketed as "Mounjaro drops" or "tirzepatide drops" online are unregulated, often don't contain real tirzepatide, and have no clinical evidence behind them.
Table of contents
- The 30-second answer
- Why "Mounjaro drops" became a search term
- What's actually in the bottles being sold as drops
- Why oral tirzepatide doesn't work (the science)
- Real Mounjaro: how it's made, dosed, and delivered
- The legitimate oral GLP-1 option (and why it's not Mounjaro)
- Red flags when shopping for tirzepatide online
- Compounded tirzepatide: legitimate, but still injectable
- FAQ
- Footer disclaimers
Why "Mounjaro drops" became a search term
Search interest in "Mounjaro drops" started climbing in late 2023, right as Mounjaro shortages peaked and patients started looking for alternatives. The phrase shows up most often in three places: TikTok videos pitching weight-loss drops, marketplace listings on sites that aren't U.S. pharmacies, and Spanish-language ads on Facebook and Instagram.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →The marketing pitch is simple. Drops sound easier than injections. Drops sound cheaper. Drops sound like they don't require a prescription. None of those claims hold up under scrutiny, but the search volume is real, and people are buying.
Eli Lilly, the manufacturer of Mounjaro, has confirmed in public statements and FDA correspondence that they do not produce any oral or sublingual formulation of tirzepatide. Every legitimate dose of Mounjaro is a clear liquid in a single-use injection pen, dispensed by a U.S. pharmacy with a valid prescription.
So the question "do Mounjaro drops work" has a clean answer: there's no such product to evaluate. What's being sold under that name is something else entirely, and that's where things get worth digging into.
What's actually in the bottles being sold as drops
Independent lab testing of products marketed online as "Mounjaro drops," "tirzepatide drops," or "GLP-1 drops" has been published in a few peer-reviewed and FDA-issued reports. The pattern is consistent.
Most bottles contain one of four things:
- Herbal blends with no GLP-1 activity. Berberine, green tea extract, chromium, glucomannan. These ingredients have mild metabolic effects but nothing comparable to tirzepatide. The label often calls the product "GLP-1 drops" without listing tirzepatide as an ingredient at all.
- Homeopathic dilutions. A trace amount of an unrelated compound diluted to the point where no active molecule remains. The label may technically list "tirzepatide" but at a dilution that delivers zero therapeutic activity.
- Counterfeit peptide solutions. Actual peptide content, often not tirzepatide. FDA seizures from 2024 found products labeled as tirzepatide that contained semaglutide, insulin, or unidentified peptides at unverified concentrations.
- Nothing. Saline or water with flavoring. The 2024 FDA warning letters to several online sellers flagged products with no detectable active ingredient.
The FDA issued multiple warning letters in 2024 and early 2025 to companies selling unapproved tirzepatide products through online channels. None of those products have been authorized for sale, and several have been removed from major payment processors and marketplaces.
If you've already bought a "drops" product, the practical advice is: don't take it, and don't get your blood work or weight tracking confused with what a real GLP-1 medication would do. The placebo effect is real, but it isn't a substitute for an FDA-approved or properly compounded medication.
Why oral tirzepatide doesn't work (the science)
There's a reason every approved GLP-1 medication except one is injected, and that reason is biology.
Tirzepatide is a peptide. Peptides are short chains of amino acids, and amino acids are exactly what your stomach is built to digest. The acid environment of the stomach (pH around 1.5 to 3) hydrolyzes peptide bonds. Pancreatic enzymes finish the job in the small intestine. By the time anything that started as oral tirzepatide reached your bloodstream, it would be a pile of free amino acids with no biological activity.
This is the same reason insulin can't be taken as a pill. The molecule gets digested before it can do anything.
Three workarounds exist, and tirzepatide hasn't successfully used any of them yet:
- Permeation enhancers. Compounds like SNAC (sodium N-(8-[2-hydroxybenzoyl]amino)caprylate) protect the peptide from acid and help it cross the gut wall. This is the technology behind oral semaglutide (Rybelsus). Rybelsus works, but bioavailability is around 1%. You take 14 mg orally to get the equivalent effect of a small fraction of an injected dose. The technology hasn't been demonstrated for tirzepatide.
- Sublingual or buccal absorption. Drops or sprays held under the tongue, theoretically absorbed across mucosal membranes. The problem: tirzepatide is a 4.8 kilodalton molecule. Sublingual mucosa absorbs molecules under about 500 daltons reliably. A 4,800-dalton peptide doesn't cross the membrane in any clinically useful amount.
- Topical or transdermal. Same molecular weight problem, plus the skin barrier. No serious clinical research suggests topical tirzepatide reaches systemic circulation.
In short, the only reason injectable tirzepatide works is that it bypasses the gut entirely. Drops can't bypass the gut. The math doesn't work.
Real Mounjaro: how it's made, dosed, and delivered
Mounjaro is manufactured by Eli Lilly as a sterile, clear, colorless to slightly yellow solution containing tirzepatide at one of six concentrations matching the available pen doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg).
Each dose comes in a single-use, pre-filled auto-injector pen. The pen contains 0.5 mL of solution, with the concentration adjusted so each pen delivers the labeled dose. You hold the pen against your skin (abdomen, thigh, or upper arm), press the button, and the spring-loaded needle injects the medication subcutaneously over a few seconds. The entire process takes about 10 seconds.
The standard dosing schedule:
| Week | Dose | Notes |
|---|---|---|
| 1 to 4 | 2.5 mg | Starter dose; not therapeutic |
| 5 to 8 | 5 mg | First therapeutic dose |
| 9 to 12 | 7.5 mg (optional) | Step-up if needed |
| 13 to 16 | 10 mg | Common maintenance dose |
| 17+ | 12.5 to 15 mg | Higher doses for greater effect |
Most patients are titrated up over 16 to 20 weeks. Some hold at 5 or 10 mg if those doses are working. The maximum approved dose is 15 mg weekly.
The cost of brand-name Mounjaro without insurance runs around $1,000 to $1,200 per month at U.S. retail pharmacies. With manufacturer savings cards or insurance coverage, that drops to anywhere from $25 to $550 monthly depending on the plan.
There is no version of this product that comes in a dropper bottle, a spray, a pill, a patch, or a sublingual tablet. If a website is selling something that looks like one of those formats and calling it Mounjaro, it isn't Mounjaro.
The legitimate oral GLP-1 option (and why it's not Mounjaro)
The one legitimate oral GLP-1 medication is Rybelsus, manufactured by Novo Nordisk. Rybelsus contains semaglutide (the same active ingredient in Ozempic and Wegovy) formulated with a permeation enhancer that allows roughly 1% bioavailability when taken on an empty stomach with a small sip of water.
Rybelsus is FDA-approved for type 2 diabetes, not weight loss, though doctors sometimes prescribe it off-label. The doses come in 3 mg, 7 mg, and 14 mg tablets, taken once daily.
Two things to know:
- Rybelsus is semaglutide, not tirzepatide. The two molecules are different. Tirzepatide hits both GLP-1 and GIP receptors and produces larger weight loss in clinical trials. Semaglutide hits only GLP-1.
- Even Rybelsus has strict dosing rules: take it on an empty stomach, with no more than 4 ounces of plain water, and wait 30 minutes before eating, drinking anything else, or taking other medications. Miss those windows and absorption drops further.
So if you specifically want oral GLP-1 treatment, Rybelsus exists. If you specifically want tirzepatide, you need an injection. There is no oral tirzepatide on the market.
Red flags when shopping for tirzepatide online
The supplement and gray-market space around GLP-1 medications has grown chaotic. Most of the obvious red flags repeat across scam sellers:
- No prescription required. Real tirzepatide, brand-name or compounded, requires a prescription. Period. If a site is selling "tirzepatide" with no medical evaluation, it isn't tirzepatide.
- Oral, sublingual, topical, or drops format. Any non-injectable format claiming to be tirzepatide is either misbranded or fake.
- Prices dramatically below market. Brand-name Mounjaro is roughly $1,000/month. Legitimate compounded tirzepatide runs $200 to $500 monthly. A "tirzepatide" product at $40 is something else.
- No mention of a U.S. pharmacy. Real compounded tirzepatide ships from a state-licensed compounding pharmacy with a verifiable address and license number. Look for the pharmacy name and check it against the National Association of Boards of Pharmacy database.
- Claims of FDA approval for compounded versions. Compounded tirzepatide is not FDA-approved. A site claiming otherwise is misrepresenting the product. Legitimate platforms are upfront about this.
- No physician consultation step. Even compounded tirzepatide requires a licensed provider to evaluate eligibility and write a prescription. Sites that skip this step aren't following federal law.
- Sketchy customer service or no return address. A real telehealth platform has a U.S. address, a phone number that gets answered, and a clinical team you can contact.
A useful sanity check: search the seller's name plus "FDA warning letter." If they've received one, that's published on the FDA website.
Compounded tirzepatide: legitimate, but still injectable
There's a real category of tirzepatide that isn't brand-name Mounjaro or Zepbound. Compounded tirzepatide is prepared by state-licensed compounding pharmacies in response to individual prescriptions. During the FDA-declared shortage of brand-name tirzepatide (October 2022 to October 2024), compounding was permitted under section 503A of the federal Food, Drug, and Cosmetic Act.
The shortage status of tirzepatide has shifted. In 2024 the FDA removed tirzepatide from the official shortage list, then re-added and removed it again in subsequent months. The legal framework for compounding tirzepatide changes when the shortage status changes. Reputable compounding pharmacies update their offerings as the regulations shift.
Two things stay constant regardless of the regulatory environment:
- Compounded tirzepatide is still injectable. The active ingredient is the same peptide as brand-name tirzepatide, with the same molecular weight and the same biological behavior. It can't be made into drops for the same biological reasons.
- Compounded tirzepatide should be dispensed by a licensed pharmacy in response to a prescription from a licensed provider. If those steps aren't happening, the product isn't legitimately compounded.
For more on what compounded tirzepatide is and how to evaluate it, see our reconstitution guide and our unit conversion chart.
What patients should do instead
If you're looking at "Mounjaro drops" because you want a real GLP-1 medication for weight loss, the realistic options are:
- Brand-name Mounjaro or Zepbound. Both contain tirzepatide. Mounjaro is approved for type 2 diabetes; Zepbound is approved for chronic weight management. Insurance coverage varies. The Lilly Direct program and manufacturer savings cards can reduce out-of-pocket costs.
- Brand-name Wegovy or Ozempic. Both contain semaglutide. Wegovy is approved for weight loss; Ozempic is approved for diabetes. Slightly less weight loss in head-to-head data versus tirzepatide, but more years of post-marketing safety data.
- Compounded semaglutide or tirzepatide. Available through telehealth platforms that work with state-licensed compounding pharmacies. The product is still injectable. Cost is typically 50 to 70% lower than brand-name.
- Rybelsus. The one legitimate oral GLP-1 medication. Semaglutide, not tirzepatide. Approved for diabetes; sometimes used off-label for weight loss.
The one option that doesn't lead anywhere useful: drops, sprays, patches, or pills that aren't Rybelsus and claim to deliver GLP-1 medication. The science doesn't support it, and the products being sold don't deliver what they claim.
FAQ
Are Mounjaro drops a real product?
No. Mounjaro is only sold as a subcutaneous injection. Eli Lilly does not manufacture an oral, sublingual, or topical version. Products labeled as "Mounjaro drops" online are unregulated and often contain no tirzepatide.
Why doesn't oral tirzepatide work?
Tirzepatide is a peptide and gets digested by stomach acid and pancreatic enzymes if swallowed. The molecule is also too large (4.8 kilodaltons) for sublingual or transdermal absorption in clinically useful amounts.
Is there an oral GLP-1 medication that does work?
Yes. Rybelsus (oral semaglutide) is FDA-approved for type 2 diabetes. It uses a permeation enhancer to achieve about 1% bioavailability when taken correctly. Bioavailability is dose-dependent and dosing rules are strict.
Can sublingual tirzepatide be absorbed under the tongue?
No. Sublingual mucosa reliably absorbs molecules under about 500 daltons. Tirzepatide is roughly 4,800 daltons, ten times too large for meaningful sublingual absorption.
What is in the bottles being sold as "tirzepatide drops"?
Independent testing has found herbal blends, homeopathic dilutions, counterfeit peptides (often semaglutide rather than tirzepatide), or saline with no active ingredient. The FDA has issued multiple warning letters to sellers in this space.
Is compounded tirzepatide the same as Mounjaro?
The active ingredient is the same peptide, but compounded tirzepatide is not FDA-approved and not interchangeable with brand-name Mounjaro. It must be dispensed by a state-licensed compounding pharmacy in response to a valid prescription.
How much does real Mounjaro cost?
Brand-name Mounjaro runs around $1,000 to $1,200 per month at U.S. retail pharmacies without insurance. With manufacturer savings cards or insurance, costs can drop to $25 to $550 monthly depending on coverage.
Why do "drops" sellers claim sublingual absorption works for tirzepatide?
Marketing copy. The molecular weight argument settles the question. Sellers either don't understand the biology or are betting customers won't check.
Are tirzepatide drops legal?
Most sellers are operating outside FDA regulation. Selling unapproved drug products is technically illegal under the Food, Drug, and Cosmetic Act. The FDA has issued warning letters, but enforcement against international or fly-by-night sellers is limited.
Can I get tirzepatide without a prescription?
No. Tirzepatide, in any legitimate form, requires a prescription from a licensed provider. Any seller offering it without a medical evaluation isn't dispensing legitimate product.
What about transdermal tirzepatide patches?
Same molecular weight problem as sublingual delivery. Tirzepatide is too large to cross intact skin in clinically meaningful amounts. No published research supports a working transdermal formulation.
If drops don't work, why are they so popular online?
A combination of cost (drops are cheap to manufacture), marketing (drops feel less intimidating than injections), and lack of regulatory enforcement against international sellers. Popularity isn't the same as efficacy.
What should I do if I already bought "Mounjaro drops"?
Don't take them. Throw the product away. If you experienced any adverse effects, report them to MedWatch (the FDA's adverse event reporting system) at fda.gov/medwatch. Talk with a licensed provider about legitimate options.
Author / review note
Reviewed by the FormBlends Medical Team. References include the Mounjaro prescribing information (Eli Lilly, 2024), the SURPASS clinical trial program (Frias et al., NEJM, 2021), FDA warning letters issued to compounding and online pharmacies in 2024 to 2025, and the 2023 publication on Rybelsus oral semaglutide bioavailability (Buckley et al., Science Translational Medicine).
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Mounjaro, Zepbound, and Rybelsus are registered trademarks of Eli Lilly and Company and Novo Nordisk respectively. Ozempic and Wegovy are registered trademarks of Novo Nordisk. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
JSON-LD FAQPage schema
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →